Fresenius Medical Care AGXETR: FME

Release of a capital market information

· Issued by Fresenius Medical Care AG via EQS

Summary by 6ix AI

Fresenius Medical Care AG bought back 1,031,000 of its own shares in the period from October 5, 2026 to October 9, 2026 (each inclusive), under the first tranche, meaning the first part, of its share buyback.

Key details

  • A total of 10,086,265 shares has been acquired so far under the first tranche of the share buyback, whose start was disclosed on May 28, 2026.
  • The purchases listed were made on October 7, 8 and 9, 2026 on four trading venues, identified by the codes CEUX, XETR, AQEU and TQEX.
  • On October 9, 2026, 218,000 shares were bought back on XETR at a weighted average price of EUR 37.6509, for a transaction volume of EUR 8,207,896.20.
  • The shares are bought by a credit institution commissioned by Fresenius Medical Care AG, and the company will provide regular information on the buyback's progress.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/fresenius-medical-care-ag-release-of-a-capital-market-information-2

Watch Fresenius Medical Care's latest callFresenius Medical Care (Xetra:FME) Q2 2026 Earnings Call · Replay · Aug 4Read the transcript of Fresenius Medical Care (Xetra:FME) Q2 2026 Earnings Call

EQS Post-admission Duties announcement: Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014
Fresenius Medical Care AG : Release of a capital market information

12.10.2026 / 16:37 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Fresenius Medical Care AG: Share buyback

Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report

In the period from October 5, 2026 to October 9, 2026 (each inclusive), 1,031,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

DateAcquired shares (number)Weighted average price (in EUR)Transaction volume
(in EUR)		Trading venue
7 October 2026 95,000 37.4565 3,558,367.50 CEUX
7 October 2026 180,000 37.8554 6,813,972.00 XETR
8 October 2026 33,000 36.6252 1,208,631.60 AQEU
8 October 2026 111,000 36.6279 4,065,696.90 CEUX
8 October 2026 16,000 36.6233 585,972.80 TQEX
8 October 2026 206,000 36.6315 7,546,089.00 XETR
9 October 2026 35,500 37.6503 1,336,585.65 AQEU
9 October 2026 119,000 37.6499 4,480,338.10 CEUX
9 October 2026 17,500 37.6485 658,848.75 TQEX
9 October 2026 218,000 37.6509 8,207,896.20 XETR

A total of 10,086,265 shares has been acquired within the framework of the first tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.


12.10.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

Language: English
Company: Fresenius Medical Care AG
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
LEI Code: 549300CP8NY40UP89Q40

 
End of News EQS News Service

2414336  12.10.2026 CET/CEST

Fresenius Medical Care AG on 6ix

Earlier from Fresenius Medical Care

All Fresenius Medical Care news releases